LEADER 03301nam  22006135  450 
001 9910254546303321
005 20200629120053.0
010   $a3-319-28216-6
024 7 $a10.1007/978-3-319-28216-9
035   $a(CKB)3710000000667239
035   $a(EBL)4528448
035   $a(DE-He213)978-3-319-28216-9
035   $a(MiAaPQ)EBC4528448
035   $a(PPN)194078736
035   $a(EXLCZ)993710000000667239
100   $a20160514d2016      u|             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHandbook of HER2-Targeted Agents in Breast Cancer$b[electronic resource] /$fby Ricardo H Alvarez, Javier Cortés, Mary Falzon, Michael Gandy, Luca Gianni, Nadia Harbeck, Martine Piccart
205   $a2nd ed. 2016.
210  1$aCham :$cSpringer International Publishing :$cImprint: Adis,$d2016.
215   $a1 online resource (117 p.)
300   $aDescription based upon print version of record.
311   $a3-319-28214-X 
320   $aIncludes bibliographical references at the end of each chapters.
327   $aIntroduction and background biology -- HER2 testing -- HER2-positive breast cancer: neoadjuvant and adjuvant therapy -- HER2-positive metastatic breast cancer: first-line treatment -- HER2-positive metastatic breast cancer: second-line treatment -- Emerging targeted agents for HER2-positive breast cancer.
330   $aThis concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.
606   $aOncology  
606   $aPrimary care (Medicine)
606   $aRadiology
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
606   $aPrimary Care Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H51000
606   $aDiagnostic Radiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H29013
615  0$aOncology  .
615  0$aPrimary care (Medicine).
615  0$aRadiology.
615 14$aOncology.
615 24$aPrimary Care Medicine.
615 24$aDiagnostic Radiology.
676   $a610
700   $aAlvarez$b Ricardo H$4aut$4http://id.loc.gov/vocabulary/relators/aut$0860186
702   $aCortés$b Javier$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aFalzon$b Mary$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aGandy$b Michael$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aGianni$b Luca$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aHarbeck$b Nadia$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aPiccart$b Martine$4aut$4http://id.loc.gov/vocabulary/relators/aut
906   $aBOOK
912   $a9910254546303321
996   $aHandbook of HER2-targeted agents in breast cancer$91919318
997   $aUNINA